POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Did Not Advance

Louisiana House Bill 778 Regulates Synthetic Kratom and Sets Penalties for Possession and Distribution

Original title: CONTROLLED SUBSTANCES: Provides with respect to the possession of Kratom (OR SEE FISC NOTE GF EX)

Last action · May 19, 2026: Involuntarily deferred in committee.Sponsor: Beryl Amedée

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

House Bill 778 prohibits the unauthorized possession, production, and distribution of synthetic kratom, establishing criminal penalties and fines for violations. The measure classifies , , and under Schedule I controlled substances and places strict limits on alkaloid and residual solvent levels in kratom products.

Why it matters

Manufacturers, distributors, and individuals handling kratom products face new criminal liability, varying fines up to $50,000, and mandatory prison terms depending on the aggregate weight and synthetic nature of the substance.

Background
  • Kratom is a tropical tree native to Southeast Asia whose leaves contain compounds with opioid receptor activity. context
  • Beryl Amedee serves as a member of the Louisiana House of Representatives representing District 51. context

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

manufacturers of kratom products

Manufacturers face new criminal liability, product formulation restrictions based on alkaloid and solvent levels, and mandatory fines or imprisonment for unauthorized production.

Directly affected

individuals possessing kratom

Individuals possessing natural or synthetic kratom are subject to specific weight-based fines, misdemeanor convictions, or felony imprisonment with or without hard labor.

Key Facts

  • Classifies 7-hydroxymitragynine, mitragynine, and tianeptine under Schedule I miscellaneous controlled substances.
  • Bans the knowing production, manufacture, distribution, dispensing, or possession with intent to distribute of kratom.
  • Sets fines up to $50,000 and imprisonment with or without hard labor for one to three years for manufacturing or distributing less than five hundred grams of kratom.
  • Sets fines up to $50,000 and imprisonment with or without hard labor for one to five years for manufacturing or distributing five hundred grams or more of kratom.
Show all 11 facts
  • Establishes a fine of not more than $100 for possessing twenty grams or less of kratom.
  • Establishes a fine of not more than $500 and parish jail imprisonment for not more than six months for a first conviction of possessing more than twenty grams of kratom.
  • Establishes a fine of not more than $1,000 and parish jail imprisonment for not more than six months for second or subsequent convictions of possessing more than twenty grams of kratom.
  • Prohibits products with a 7-hydroxymitragynine alkaloid fraction greater than two percent of total alkaloids or exceeding one milligram per single serving.
  • Prohibits natural mitragynine extracted with solvents resulting in residual levels higher than allowed in U.S. Pharmacopeia 467 or serving sizes greater than eighty milligrams.
  • Imposes a $500 fine for unlawful possession of two grams or less of a synthesized kratom product.
  • Imposes a fine of at least $2,000 and imprisonment for one to five years with or without hard labor for possessing more than two grams, cultivating, producing, or distributing synthesized kratom.

Frequently Asked Questions

What is the penalty for possessing two grams or less of synthesized kratom?
A person who unlawfully possesses two grams or less of a synthesized kratom product shall be fined five hundred dollars.
How is kratom defined in the proposed law?
Kratom means any substance derived from the leaves of the Mitragyna speciosa tree or any substance containing or .
What are the restrictions on 7-hydroxymitragynine in products?
Products cannot contain an greater than two percent of total alkaloids in a container, and single servings cannot exceed one milligram.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

This bill did not become law - Died at adjournment · in House committee.

Procedural history

5 actions
  1. May 19, 2026House
    Involuntarily deferred in committee.
  2. Mar 9, 2026HouseIntroduced
    Read by title, under the rules, referred to the Committee on Administration of Criminal Justice.
  3. Feb 27, 2026House
    Prefiled.
  4. Feb 27, 2026HouseCommittee
    Under the rules, provisionally referred to the Committee on Administration of Criminal Justice.
  5. Feb 27, 2026House
    First appeared in the Interim Calendar on 2/27/2026.

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Expansion of Controlled Substance Schedules

The bill moves from a general prohibition framework to specifying exact chemical thresholds, residual solvent standards, and differentiated penalties for natural versus synthetic kratom derivatives.

Connected Entities

Beryl Amedée, United States Food and Drug Administration
PersonBeryl Amedée“Representative who authored House Bill 778”Map →
OrganizationUnited States Food and Drug Administration“Federal agency referenced regarding pharmaceutical product approvals and food so”Map →

Sources

Open source document

www.legis.la.gov

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 75)
  • Controversy65
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record